Post-Approval Safety Study (PASS) of Lenalidomide Compared with Other Treatments In Patients with Relapsed or Refractory Multiple Myeloma: Evaluation of Peripheral Neuropathy In the First 1,011 PatientsMichel Delforge, Renato Zambello, Miguel‐Teodoro Hernández et al.|Blood|2010Cited by 1